Kinnevik Technology Partners

What they fund

• Technology-enabled growth businesses across Europe and the US [1].
• Companies in healthcare, software, and climate sectors [1].
• Passionate founders building industry leaders [1].
• Investments at all stages of the growth journey [1].
• Patient capital from its own balance sheet [1].

Investment thesis

Kinnevik is a leading growth investor, active owner and operational partner providing patient capital to challenger technology-enabled businesses in Europe and the US [1]. The firm invests across all stages of a company's growth journey, backed by its own balance sheet to create long-term shareholder value [1]. It focuses on passionate founders building tomorrow's leaders within healthcare, software, and climate [1]. The strategy is to back challengers reimagining everyday life and redefining industries [1]. Credibility: Kinnevik's homepage explicitly outlines its mission, target sectors, and investment philosophy [1].

Value add

Kinnevik acts as an active owner and operational partner, providing patient capital to create long-term value [1]. It focuses on backing challengers to redefine industries [1]. Fit verdict: Ideal for scaling tech companies needing operational support and long-term capital. Founder diligence script: 1. How does Kinnevik's operational support integrate with our leadership team? 2. What is the typical timeline for their active ownership involvement? 3. How do they measure long-term shareholder value in our sector? 4. What is their approach to follow-on funding in subsequent rounds? 5. How do they help us navigate industry redefinition?

Portfolio focus

• Spring Health: digital mental health platform [1].
• Mews: hospitality technology platform [1].
• Pleo: corporate spend management software [1].
• Cityblock: healthcare delivery for underserved communities [1].
• Oviva: digital weight management and wellness platform [1].

Notable investments & exits

• Tandem Health: Exit details not specified in the provided documents [1].
• Strand Therapeutics: Exit details not specified in the provided documents [1].
• Enveda: Exit details not specified in the provided documents [1].
• The firm has distributed 87.7 SEKbn since 2018, indicating successful exits [1].

Strategic implications

Kinnevik's balance-sheet-backed model allows for patient capital, reducing pressure for quick exits. Focus on healthcare, software, and climate aligns with long-term megatrends. Active ownership model requires deep operational integration, which may limit the number of investments they can manage effectively.

Where they could go further

Expand operational support to include AI integration strategies, given the 'Building businesses in age of AI' theme [1]. Develop a more structured co-investment framework to attract external capital and increase deployment capacity. Enhance transparency around exit timelines and performance metrics to build founder trust.